M.A. Richard

Combined treatment with low‐dose methotrexate and initial short‐term superpotent topical steroids in bullous pemphigoid: an open, multicentre, retrospective study

H. Maillard, M. Richard, B. Guillot, 2011, The British journal of dermatology.

Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy: Follow-Up of the Ritux 3 Trial.

E. Houivet, S. Calbo, C. Prost-Squarcioni, 2024, JAMA dermatology.

Omalizumab in the treatment of bullous pemphigoid resistant to first-line therapy: a French national multicentre retrospective study of 100 patients.

T. Gille, E. Brenaut, C. Prost-Squarcioni, 2023, The British journal of dermatology.